- Works count
- 629
- Citation count
- 29,523
- H-index
- 62
- i10-index
- 212
Research interests
Publications
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
New England Journal of Medicine · 2022 · https://doi.org/10.1056/nejmoa2203690
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer
New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1914510
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
Journal of Clinical Oncology · 2017 · https://doi.org/10.1200/jco.2017.75.6155
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
Journal of Clinical Oncology · 2017 · https://doi.org/10.1200/jco.2017.73.7585
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
The Lancet · 2012 · https://doi.org/10.1016/s0140-6736(11)61847-3
Current projects
No projects listed.